No fee increases, but a review against the backdrop of potential new processes as a result of the Health Technology Assessment Review suggests change is coming.
Stability now, change later? Fees unchanged while department undertakes charging model review
May 1, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 1 May
May 1, 2026 - - Podcast -
UCB marks 25 years in Australia and advances national life science strategy
May 1, 2026 - - Latest News -
Stability now, change later? Fees unchanged while department undertakes charging model review
May 1, 2026 - - Latest News -
Bridge Program celebrates ten years of translating research into patient outcomes
May 1, 2026 - - Latest News -
New oral treatment offers more options for Australians with metastatic colorectal cancer
April 30, 2026 - - Latest News -
Moderna taps Salesforce to unify global commercial operations
April 30, 2026 - - Latest News -
How do we know the HTA institution loves patients? Because they use a love heart emoji
April 30, 2026 - - Latest News
